Results 181 to 190 of about 2,190 (195)

Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits

Pharmaceutical Development and Technology, 2018
Jiaxin Pi, Dongli Qi, Pan Guo
exaly  

Side-Effect Profile of Brimonidine Tartrate in Children

Yearbook of Ophthalmology, 2006
openaire   +1 more source

Ocular inserts based on chitosan and brimonidine tartrate: Development, characterization and biocompatibility

Journal of Drug Delivery Science and Technology, 2016
Carlos Jensen, Gisele Silva, Gabriella Maria Fernandes Cunha   +2 more
exaly  

Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients

Ophthalmology, 2002
Catherine Jui-Ling Liu, Ching-Yu Cheng, Wen-Ming Hsu   +2 more
exaly  

In vitro characterization of a controlled-release ocular insert for delivery of brimonidine tartrate

Acta Biomaterialia, 2014
exaly  

Chick chorioallantoic membrane model forin ovoevaluation of timolol maleate–brimonidine tartrate ocular inserts

Drug Delivery, 2014
exaly  

The Safety and Intraocular Pressure–Lowering Efficacy of Brimonidine Tartrate 0.15% Preserved with Polyquaternium-1

Ophthalmology, 2006
Jess T Whitson
exaly  

Brimonidine tartrate: risk of serious corneal opacity

Reactions Weekly
openaire   +1 more source

Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension

Ophthalmology, 1998
exaly  

Brimonidine Tartrate Gel Hits Phase III Trial End Points

Skin & Allergy News, 2012
openaire   +1 more source